MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Choo, Kong Bung ^a   Soon, Yuen Loon ^a   Nguyen, Phan Nguyen Nhi ^a   Hiew, Michele Sook Yuin ^a   Huang, Chiu Jung ^b  

^a UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^b CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

Colon cancer; microRNA 5p and 3p pairs; miRNA cross targeting; Safe proof regulation

Indexed keywords

K RAS PROTEIN; MICRORNA; MICRORNA 141; MICRORNA 141 3P; MICRORNA 141 5P; MICRORNA 17 3P; MICRORNA 17 5P; MICRORNA 18A 3P; MICRORNA 18A 5P; MICRORNA 200A; MICRORNA 200A 3P; MICRORNA 200A 5P; MICRORNA 200B; MICRORNA 200B 3P; MICRORNA 200B 5P; MICRORNA 20A; MICRORNA 20A 3P; MICRORNA 20A 5P; MICRORNA 3P; MICRORNA 5P; MICRORNA LET7D 3P; MICRORNA LET7D 5P; MICRORNA LET7G 3P; MICRORNA LET7G 5P; MICRORNA LET7I 3P; MICRORNA LET7I 5P; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; RNA;

3' UNTRANSLATED REGION; ANGIOGENESIS; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL LINE; CELL CYCLE; CO EXPRESSION; COLON; COLON CANCER; COLON CANCER CELL LINE; CONTROLLED STUDY; CROSS TARGETING; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MULTIGENE FAMILY; MULTIPLE CANCER; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; UPREGULATION; BIOSYNTHESIS; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICRORNAS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, IGF TYPE 1; RNA, NEOPLASM;

EID: 84907930230     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-014-0095-x     Document Type: Article

References (71)

1. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. JS Yang, EC Lai, Mol Cell 2011 43 892 903 10.1016/j.molcel.2011.07.024 21925378
2. Many roads to maturity: microRNA biogenesis pathways and their regulation. J Winter, S Jung, S Keller, RI Gregory, S Diederichs, Nat Cell Biol 2009 11 228 234 10.1038/ncb0309-228 19255566
3. Tissue-dependent paired expression of miRNAs. S Ro, C Park, D Young, KM Sanders, W Yan, Nucleic Acids Res 2007 35 5944 5953 10.1093/nar/gkm641 17726050
4. Deep sequencing of small RNA libraries reveals dynamic regulation of conserved and novel microRNAs and microRNA-stars during silkworm development. G Jagadeeswaran, Y Zheng, N Sumathipala, H Jiang, EL Arrese, JL Soulages, W Zhang, R Sunkar, BMC Genomics 2010 11 52 10.1186/1471-2164-11-52 20089182
5. MicroRNA evolution by arm switching. S Griffiths-Jones, JH Hui, A Marco, M Ronshaugen, EMBO Rep 2011 12 172 177 10.1038/embor.2010.191 21212805
6. Comprehensive analysis of mammalian miRNA∗ species and their role in myeloid cells. F Kuchenbauer, SM Mah, M Heuser, A McPherson, J Ruschmann, A Rouhi, T Berg, L Bullinger, B Argiropoulos, RD Morin, D Lai, DT Starczynowski, A Karsan, CJ Eaves, A Watahiki, Y Wang, SA Aparicio, A Ganser, J Krauter, H Döhner, K Döhner, MA Marra, FD Camargo, L Palmqvist, C Buske, RK Humphries, Blood 2011 118 3350 3358 10.1182/blood-2010-10-312454 21628414
7. Widespread regulatory activity of vertebrate microRNA∗ species. JS Yang, MD Phillips, D Betel, P Mu, A Ventura, AC Siepel, KC Chen, EC Lai, RNA 2011 17 312 326 10.1261/rna.2537911 21177881
8. The regulatory activity of microRNA∗ species has substantial influence on microRNA and 3' UTR evolution. K Okamura, MD Phillips, DM Tyler, H Duan, YT Chou, EC Lai, Nat Struct Mol Biol 2008 15 354 363 10.1038/nsmb.1409 18376413
9. The fate of miRNA∗ strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule? L Guo, Z Lu, PLoS One 2010 5 11387 10.1371/journal.pone.0011387 20613982
10. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. K Jazdzewski, S Liyanarachchi, M Swierniak, J Pachucki, MD Ringel, B Jarzab, A de la Chapelle, Proc Natl Acad Sci U S A 2009 106 1502 1505 10.1073/pnas.0812591106 19164563
11. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. L Jiang, Q Huang, S Zhang, Q Zhang, J Chang, X Qiu, E Wang, BMC Cancer 2010 10 318 10.1186/1471-2407-10-318 20569443
12. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. MI Almeida, MS Nicoloso, L Zeng, C Ivan, R Spizzo, R Gafa, L Xiao, X Zhang, I Vannini, F Fanini, M Fabbri, G Lanza, RM Reis, PA Zweidler-McKay, GA Calin, Gastroenterology 2012 142 886 896 e889 10.1053/j.gastro.2011.12.047 22240480
13. Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells. EC Martin, S Elliott, LV Rhodes, JW Antoon, C Fewell, Y Zhu, JL Driver, M Jodari-Karimi, CW Taylor, EK Flemington, BS Beckman, BM Collins-Burow, ME Burow, Mol Carcinog 2012 53 38 48 10.1002/mc.21946 22911661
14. Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. SW Shan, L Fang, T Shatseva, ZJ Rutnam, X Yang, W Du, WY Lu, JW Xuan, Z Deng, BB Yang, J Cell Sci 2013 126 Pt 6 1517 1530 10.1242/jcs.122895 23418359
15. Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha. W Koh, CT Sheng, B Tan, QY Lee, V Kuznetsov, LS Kiang, V Tanavde, BMC Genomics 2010 11 Suppl 1 6 10.1186/1471-2164-11-S1-S6 20158877
16. Regulated expression of microRNAs-126/126∗ inhibits erythropoiesis from human embryonic stem cells. X Huang, E Gschweng, B Van Handel, D Cheng, HK Mikkola, ON Witte, Blood 2011 117 2157 2165 10.1182/blood-2010-08-302711 21163928
17. Global cancer statistics, 2002. DM Parkin, F Bray, J Ferlay, P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
18. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. O Slaby, M Svoboda, J Michalek, R Vyzula, Mol Cancer 2009 8 102 10.1186/1476-4598-8-102 19912656
19. MicroRNAs in colorectal cancer metastasis. I de Krijger, LJ Mekenkamp, CJ Punt, ID Nagtegaal, J Pathol 2011 224 438 447 10.1002/path.2922 21706478
20. MicroRNA Expression in Selected Carcinomas of the Gastrointestinal Tract. NC Panarelli, RK Yantiss, Patholog Res Int 2011 2011 124608 21403819
21. MicroRNA in colorectal cancer: from benchtop to bedside. WK Wu, PT Law, CW Lee, CH Cho, D Fan, K Wu, J Yu, JJ Sung, Carcinogenesis 2011 32 247 253 10.1093/carcin/bgq243 21081475
22. Frequent Co-expression of miRNA-5p and -3p species and cross-targeting in induced pluripotent stem cells. CJ Huang, PN Nguyen, KB Choo, S Sugii, K Wee, SK Cheong, T Kamarul, Int J Med Sci 2014 11 824 833 10.7150/ijms.8358 24936146
23. Nuclear factor kappa B and tumor necrosis factor-alpha modulation of transcription of the mouse testis- and pre-implantation development-specific Rnf33/Trim60 gene. KB Choo, MC Hsu, YH Tsai, WY Lin, CJ Huang, FEBS J 2011 278 837 850 10.1111/j.1742-4658.2010.08002.x 21205214
24. Differential expression of speckled POZ protein, SPOP: putative regulation by miR-145. CJ Huang, HY Chen, WY Lin, KB Choo, J Biosci 2014 39 401 413 10.1007/s12038-014-9432-1 24845504
25. Correlation between metastatic potential and variants from colorectal tumor cell line HT-29. M Wang, I Vogel, H Kalthoff, World J Gastroenterol 2003 9 2627 2631 14606113
26. Cooperative anti-invasive effect of Cdc42/Rac1 activation and ROCK inhibition in SW620 colorectal cancer cells with elevated blebbing activity. M de Toledo, C Anguille, L Roger, P Roux, G Gadea, PLoS One 2012 7 48344 10.1371/journal.pone.0048344 23144867
27. MicroRNAs-the micro steering wheel of tumour metastases. MS Nicoloso, R Spizzo, M Shimizu, S Rossi, GA Calin, Nat Rev Cancer 2009 9 293 302 10.1038/nrc2619 19262572
28. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. N Cong, P Du, A Zhang, F Shen, J Su, P Pu, T Wang, J Zjang, C Kang, Q Zhang, Oncol Rep 2013 29 1579 1587 23381389
29. The role of the miR-200 family in epithelial-mesenchymal transition. PS Mongroo, AK Rustgi, Cancer Biol Ther 2010 10 219 222 10.4161/cbt.10.3.12548 20592490
30. Impact of host genes and strand selection on miRNA and miRNA∗ expression. M Biasiolo, G Sales, M Lionetti, L Agnelli, K Todoerti, A Bisognin, A Coppe, C Romualdi, A Neri, S Bortoluzzi, PLoS One 2011 6 23854 10.1371/journal.pone.0023854 21909367
31. mir-17-92, a cluster of miRNAs in the midst of the cancer network. V Olive, I Jiang, L He, Int J Biochem Cell Biol 2010 42 1348 1354 10.1016/j.biocel.2010.03.004 20227518
32. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. M Hafner, M Landthaler, L Burger, M Khorshid, J Hausser, P Berninger, A Rothballer, M Ascano Jr, AC Jungkamp, M Munschauer, A Ulrich, GS Wardle, S Dewell, M Zavolan, T Tuschl, Cell 2010 141 129 141 10.1016/j.cell.2010.03.009 20371350
33. Vascular smooth muscle cell proliferation is Influenced by let-7d microRNA and its interaction with KRAS. ML Yu, JF Wang, GK Wang, XH You, XX Zhao, Q Jing, YW Qin, Circ J 2011 75 703 709 10.1253/circj.CJ-10-0393 21266788
34. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. LR Jiao, AE Frampton, J Jacob, L Pellegrino, J Krell, G Giamas, N Tsim, P Vlavianos, P Cohen, R Ahmad, A Keller, NA Habib, J Stebbing, L Castellano, PLoS One 2012 7 32068 10.1371/journal.pone.0032068 22384141
35. miRNA∗: a passenger stranded in RNA-induced silencing complex? SM Mah, C Buske, RK Humphries, F Kuchenbauer, Crit Rev Eukaryot Gene Expr 2010 20 141 148 10.1615/CritRevEukarGeneExpr.v20.i2.40 21133843
36. The microcosmos of cancer. A Lujambio, SW Lowe, Nature 2012 482 347 355 10.1038/nature10888 22337054
37. MicroRNA-297b-5p/3p target Mllt3/Af9 to suppress lymphoma cell proliferation, migration and invasion in vitro and tumor growth in nude mice. T Zhang, Y Luo, T Wang, JY Yang, Leuk Lymphoma 2012 53 2033 2040 10.3109/10428194.2012.678005 22448917
38. miR-126 and miR-126∗ repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Y Zhang, P Yang, T Sun, D Li, X Xu, Y Rui, C Li, M Chong, T Ibrahim, L Mercatali, D Amadori, X Lu, D Xie, QJ Li, XF Wang, Nat Cell Biol 2013 15 284 294 10.1038/ncb2690 23396050
39. The role of microRNA-200 in progression of human colorectal and breast cancer. L Bojmar, E Karlsson, S Ellegård, H Olsson, B Björnsson, O Hallböök, M Larsson, O Stål, P Sandström, PLoS One 2013 8 84815 10.1371/journal.pone.0084815 24376848
40. Co-modulated behavior and effects of differentially expressed miRNA in colorectal cancer. WS Chen, TW Chen, TH Yang, LY Hu, HW Pan, CM Leung, SC Li, MR Ho, CW Shu, PF Liu, SY Yu, YT Tu, WC Lin, TT Wu, KW Tsai, BMC Genomics 2013 14 Suppl 5 12 10.1186/1471-2164-14-S5-S12 24564330
41. MicroRNA profiles discriminate among colon cancer metastasis. A Drusco, GJ Nuovo, N Zanesi, G Di Leva, F Pichiorri, S Volinia, C Fernandez, A Antenucci, S Costinean, A Bottoni, IA Rosito, CG Liu, A Burch, M Acunzo, Y Pekarsky, H Alder, A Ciardi, CM Croce, PLoS One 2014 9 96670 10.1371/journal.pone.0096670 24921248
42. Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. S Zanutto, S Pizzamiglio, M Ghilotti, C Bertan, F Ravagnani, F Perrone, E Leo, S Pilotti, P Verderio, M Gariboldi, MA Pierotti, Br J Cancer 2014 110 1001 1007 10.1038/bjc.2013.819 24423916
43. Functional siRNAs and miRNAs exhibit strand bias. A Khvorova, A Reynolds, SD Jayasena, Cell 2003 115 209 216 10.1016/S0092-8674(03)00801-8 14567918
44. Asymmetry in the assembly of the RNAi enzyme complex. DS Schwarz, G Hutvagner, T Du, Z Xu, N Aronin, PD Zamore, Cell 2003 115 199 208 10.1016/S0092-8674(03)00759-1 14567917
45. A heterozygous variant in the human cardiac miR-133 gene, MIR133A2, alters miRNA duplex processing and strand abundance. M Ohanian, DT Humphreys, E Anderson, T Preiss, D Fatkin, BMC Genet 2013 14 18 10.1186/1471-2156-14-18 23497314
46. Concordant and discordant regulation of target genes by miR-31 and its isoforms. YT Chan, YC Lin, RJ Lin, HH Kuo, WC Thang, KP Chiu, AL Yu, PLoS One 2013 8 58169 10.1371/journal.pone.0058169 23472152
47. A highly expressed miR-101 isomiR is a functional silencing small RNA. F Llorens, M Banez-Coronel, L Pantano, JA Del Rio, I Ferrer, X Estivill, E Marti, BMC Genomics 2013 14 104 10.1186/1471-2164-14-104 23414127
48. MicroRNAs from the same precursor have different targeting properties. A Marco, JI Macpherson, M Ronshaugen, S Griffiths-Jones, Silence 2012 3 8 10.1186/1758-907X-3-8 23016695
49. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. S Chiosea, E Jelezcova, U Chandran, M Acquafondata, T McHale, RW Sobol, R Dhir, Am J Pathol 2006 169 1812 1820 10.2353/ajpath.2006.060480 17071602
50. Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer. D Wu, J Tao, B Xu, P Li, Q Lu, W Zhang, Mol Med Rep 2012 5 695 699 22179432
51. Dicer, Drosha, and outcomes in patients with ovarian cancer. WM Merritt, YG Lin, LY Han, AA Kamat, WA Spannuth, R Schmandt, D Urbauer, LA Pennacchio, JF Cheng, AM Nick, MT Deavers, A Mourad-Zeidan, H Wang, P Mueller, ME Lenburg, JW Gray, S Mok, MJ Birrer, G Lopez-Berestein, RL Coleman, M Bar-Eli, AK Sood, N Engl J Med 2008 359 2641 2650 10.1056/NEJMoa0803785 19092150
52. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. G Grelier, N Voirin, AS Ay, DG Cox, S Chabaud, I Treilleux, S Leon-Goddard, R Rimokh, I Mikaelian, C Venoux, A Puisieux, C Lasset, C Moyret-Lalle, Br J Cancer 2009 101 673 683 10.1038/sj.bjc.6605193 19672267
53. Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. B Wang, S Li, HH Qi, D Chowdhury, Y Shi, CD Novina, Nat Struct Mol Biol 2009 16 12 1259 1266 10.1038/nsmb.1712 19946268
54. Sorting of Drosophila small silencing RNAs partitions microRNA∗ strands into the RNA interference pathway. M Ghildiyal, J Xu, H Seitz, Z Weng, PD Zamore, RNA 2010 16 43 56 10.1261/rna.1972910 19917635
55. Multiple sensors ensure guide strand selection in human RNAi pathways. CL Noland, JA Doudna, RNA 2013 19 639 648 10.1261/rna.037424.112 23531496
56. Argonaute proteins: potential biomarkers for human colon cancer. L Li, C Yu, H Gao, Y Li, BMC Cancer 2010 10 38 10.1186/1471-2407-10-38 20146808
57. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. ME Peter, Cell Cycle 2009 8 843 852 10.4161/cc.8.6.7907 19221491
58. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. SA Bustin, PJ Jenkins, Trends Mol Med 2001 7 447 454 10.1016/S1471-4914(01)02104-9 11597519
59. The insulin-like growth factor system as a therapeutic target in colorectal cancer. AB Hassan, VM Macaulay, Ann Oncol 2002 13 349 356 10.1093/annonc/mdf096 11996463
60. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. SJ Moschos, CS Mantzoros, Oncology 2002 63 317 332 10.1159/000066230 12417786
61. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. N Reinmuth, W Liu, F Fan, YD Jung, SA Ahmad, O Stoeltzing, CD Bucana, R Radinsky, LM Ellis, Clin Cancer Res 2002 8 3259 3269 12374697
62. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. A Hakam, TJ Yeatman, L Lu, L Mora, G Marcet, SV Nicosia, RC Karl, D Coppola, Hum Pathol 1999 30 1128 1133 10.1016/S0046-8177(99)90027-8 10534157
63. IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer. G Peters, S Gongoll, C Langner, M Mengel, P Piso, J Klempnauer, J Ruschoff, H Kreipe, R von Wasielewski, Virchows Arch 2003 443 139 145 10.1007/s00428-003-0856-5 12845531
64. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. S Freier, O Weiss, M Eran, A Flyvbjerg, R Dahan, I Nephesh, T Safra, E Shiloni, I Raz, Gut 1999 44 704 708 10.1136/gut.44.5.704 10205209
65. The insulin-like growth factor type 1 receptor and colorectal neoplasia: insights into invasion. AS Allison, MA McIntyre, C McArdle, FK Habib, Hum Pathol 2007 38 1590 1602 10.1016/j.humpath.2007.03.013 17651787
66. RAS is regulated by the let-7 microRNA family. SM Johnson, H Grosshans, J Shingara, M Byrom, R Jarvis, A Cheng, E Labourier, KL Reinert, D Brown, FJ Slack, Cell 2005 120 635 647 10.1016/j.cell.2005.01.014 15766527
67. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer. KM Smits, T Paranjape, S Nallur, KA Wouters, MP Weijenberg, LJ Schouten, PA van den Brandt, FT Bosman, JB Weidhaas, M van Engeland, Clin Cancer Res 2011 17 7723 7731 10.1158/1078-0432.CCR-11-0990 21994416
68. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer. ZH Li, XM Pan, BW Han, XM Guo, Z Zhang, J Jia, LB Gao, Tumour Biol 2013 34 3159 3163 10.1007/s13277-013-0885-x 23729275
69. Clinical relevance of KRAS in human cancers. S Jancik, J Drabek, D Radzioch, M Hajduch, J Biomed Biotechnol 2010 2010 150960 10.1155/2010/150960 20617134
70. Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf. D Esser, B Bauer, RM Wolthuis, A Wittinghofer, RH Cool, P Bayer, Biochemistry 1998 37 13453 13462 10.1021/bi9811664 9753431
71. A genome-wide survey of RAS transformation targets. J Zuber, OI Tchernitsa, B Hinzmann, AC Schmitz, M Grips, M Hellriegel, C Sers, A Rosenthal, R Schafer, Nat Genet 2000 24 144 152 10.1038/72799 10655059